D-Penicillamine USP 250mg Capsules Manufacturer & Supplier in India

Taj Medico is an established pharmaceutical manufacturer and supplier associated with D-Penicillamine USP 250mg Capsules (Penici-D) for authorized pharmaceutical procurement in India and eligible international markets. We focus on providing consistent pharmaceutical products, dependable supply coordination, and professional support to distributors, wholesalers, importers, healthcare procurement organizations, and other authorized buyers.

D-Penicillamine 250mg Capsules contain D-penicillamine, a prescription medicine with chelating and immunomodulatory properties. Depending on the clinical indication, D-penicillamine may be prescribed for Wilson’s disease, severe active rheumatoid arthritis, and cystinuria. Because this medicine can cause important adverse effects and generally requires laboratory monitoring, treatment should always be directed by a qualified healthcare professional.

Our objective is to support legitimate pharmaceutical supply requirements with appropriate product information, quality-focused manufacturing practices, packaging coordination, and documentation according to applicable market requirements.

D-Penicillamine USP 250mg Capsules – Product Overview

D-Penicillamine USP 250mg Capsules, marketed as Penici-D, are prescription capsules containing 250 mg of D-penicillamine.

D-penicillamine is a thiol-containing compound with two important pharmacological characteristics. First, it has chelating activity, allowing it to bind certain substances and facilitate their elimination. Second, it has immunomodulatory activity, which contributes to its historical use in selected inflammatory and autoimmune conditions.

The medicine has an established role in managing Wilson’s disease, in which excess copper accumulates in the body. It has also been used in cystinuria and selected patients with severe rheumatoid arthritis when considered appropriate by the treating physician.

Product DetailInformation
ProductD-Penicillamine USP 250mg Capsules
BrandPenici-D
Strength250mg
Dosage FormCapsules
Active IngredientD-Penicillamine
Therapeutic CategoryChelating / Immunomodulatory Medicine
Manufacturer/SupplierTaj Medico
Manufacturing LocationVapi, Gujarat, India
Prescription StatusPrescription medicine

D-Penicillamine 250mg Capsules Uses

D-penicillamine has several recognized clinical applications. The appropriate use, dose, treatment duration, and monitoring schedule depend on the individual patient and diagnosis.

D-Penicillamine for Wilson’s Disease

Wilson’s disease is an inherited disorder involving abnormal copper metabolism. Excess copper can accumulate in organs such as the liver and brain and may cause significant clinical complications.

D-penicillamine acts as a copper-chelating agent. It binds copper and helps increase its elimination, thereby reducing excessive copper accumulation.

Because Wilson’s disease is a chronic condition, treatment may be long term. Physicians may monitor copper-related laboratory parameters, liver function, blood counts, kidney function, and other relevant measures during therapy.

D-Penicillamine for Rheumatoid Arthritis

D-penicillamine has immunomodulatory properties and has historically been used for severe active rheumatoid arthritis in selected patients.

It is not appropriate for every patient with rheumatoid arthritis, and treatment decisions require consideration of alternative therapies, disease severity, previous treatment, and potential adverse effects.

Patients receiving D-penicillamine for rheumatoid arthritis generally require close clinical and laboratory follow-up.

D-Penicillamine for Cystinuria

D-penicillamine may also be prescribed for cystinuria, an inherited disorder that can result in cystine kidney stones.

The medicine can interact with cystine to form a more soluble complex, helping reduce cystine crystallization and stone formation. Adequate fluid intake and other measures may form part of the overall management plan determined by the treating physician.

How D-Penicillamine Works

The pharmacological action of D-penicillamine depends partly on the condition being treated.

In Wilson’s disease, its chelating properties allow it to bind copper and promote urinary elimination.

In cystinuria, D-penicillamine interacts with cystine and helps form a more soluble compound, reducing the tendency for cystine to form stones.

In inflammatory conditions such as rheumatoid arthritis, D-penicillamine has immunomodulatory effects that can influence inflammatory processes.

Because these mechanisms involve important physiological pathways, D-penicillamine should be used only according to a prescribed treatment plan.

D-Penicillamine USP 250mg Capsules Manufacturer in India

We provide pharmaceutical sourcing support for organizations searching for a D-Penicillamine USP 250mg Capsules Manufacturer in India.

India is an important pharmaceutical manufacturing center with established capabilities in formulation development, finished-dose manufacturing, quality control, packaging, and international pharmaceutical supply.

At Taj Medico, we focus on supporting authorized pharmaceutical procurement with attention to:

  • Product consistency
  • Quality-oriented manufacturing processes
  • Finished-product supply
  • Appropriate pharmaceutical packaging
  • Batch-related documentation
  • Professional customer communication
  • Domestic and international supply coordination

Specific manufacturing, regulatory, and documentation arrangements depend on the product and destination market.

D-Penicillamine 250mg Capsules Manufacturer in Vapi, Gujarat

Taj Medico is associated with pharmaceutical operations in Vapi, Gujarat, one of India’s recognized industrial and pharmaceutical regions.

For businesses searching for a D-Penicillamine 250mg Capsules Manufacturer in Vapi, Gujarat, our supply team can provide information regarding product specifications, availability, packaging, commercial requirements, and applicable documentation.

Our location also supports coordination with pharmaceutical businesses across India and with eligible international customers.

D-Penicillamine USP 250mg Capsules Supplier in Mumbai

Mumbai is a major pharmaceutical commercial and logistics center. Pharmaceutical distributors and procurement organizations in Mumbai and Maharashtra frequently require dependable connections with manufacturers and suppliers located within India’s pharmaceutical manufacturing ecosystem.

We support authorized buyers searching for D-Penicillamine USP 250mg Capsules suppliers in Mumbai, Maharashtra, subject to product availability and applicable pharmaceutical distribution requirements.

Our supply coordination can support businesses serving Mumbai as well as broader PAN-India distribution networks.

D-Penicillamine 250mg Capsules PAN India Supplier

Our pharmaceutical supply support extends to authorized customers across Indian markets. Businesses looking for D-Penicillamine 250mg Capsules PAN India suppliers can contact us to discuss their procurement requirements.

We understand that pharmaceutical distributors may require regular product availability, appropriate packaging, commercial consistency, and timely coordination. Our approach is designed to support legitimate long-term business relationships rather than one-time product transactions.

D-Penicillamine USP 250mg Capsules Exporter from India

Taj Medico also supports eligible international pharmaceutical procurement requirements.

International supply of prescription medicines requires careful attention to the regulatory framework of the importing country. Depending on the destination, buyers may need product registration, import authorization, approved labeling, certificates, quality documentation, and other regulatory materials.

We coordinate export-related requirements according to the applicable market conditions and product status.

Our potential export supply discussions may be relevant to authorized buyers across regions such as:

  • Africa
  • Middle East
  • Latin America
  • South Asia
  • Other eligible international markets

Actual availability and export eligibility depend on destination-country regulations and commercial requirements.

D-Penicillamine USP 250mg Capsules PCD Pharma Franchise

Pharmaceutical businesses searching for D-Penicillamine USP 250mg Capsules PCD Pharma Franchise opportunities may evaluate the product for inclusion in an appropriate prescription-medicine portfolio.

PCD pharmaceutical arrangements must comply with applicable licensing, distribution, promotional, prescription, and advertising requirements. Because D-penicillamine is a prescription medicine with significant monitoring considerations, responsible promotion and distribution are particularly important.

Eligible business partners can discuss:

  • Product availability
  • Territory requirements
  • Packaging
  • Commercial terms
  • Documentation
  • Distribution requirements
  • Market-specific regulatory considerations

Quality-Focused Pharmaceutical Supply

For prescription medicines, quality consistency is an essential consideration for pharmaceutical buyers.

We emphasize quality-oriented processes covering the finished pharmaceutical product, packaging, identification, storage requirements, and supply documentation. Pharmaceutical buyers should verify the applicable product specifications and regulatory documents before placing commercial orders.

The final product should be stored and transported according to the approved product information and applicable pharmaceutical handling requirements.

D-Penicillamine 250mg Capsules – Safety Information

D-penicillamine can produce adverse effects ranging from relatively mild reactions to serious complications.

Potential adverse effects may include:

  • Gastrointestinal discomfort
  • Nausea or other digestive symptoms
  • Changes in taste
  • Skin reactions
  • Mouth sores
  • Changes in blood-cell counts
  • Protein in the urine
  • Kidney-related complications
  • Autoimmune reactions

More serious reactions require prompt medical attention.

Because D-penicillamine can affect the blood, kidneys, and immune system, physicians may order regular blood and urine tests. Monitoring requirements depend on the indication, dosage, duration of treatment, and individual patient factors.

Patients should not discontinue or alter treatment without consulting their healthcare professional.

D-Penicillamine Treatment Requires Medical Monitoring

D-penicillamine is not a medicine intended for unsupervised self-treatment. Physicians may establish a monitoring schedule that includes complete blood counts, urinalysis, renal-function assessment, and other tests appropriate to the patient’s condition.

Patients should inform their healthcare professional about other medicines, supplements, allergies, pregnancy status, and relevant medical history before beginning treatment.

Any unusual bleeding, severe skin reaction, significant weakness, swelling, urinary changes, fever, or other concerning symptoms should be reported promptly to a healthcare professional.

Why Choose Taj Medico as a D-Penicillamine Manufacturer and Supplier?

We understand that pharmaceutical buyers evaluate suppliers on more than product availability. Reliable procurement requires a combination of product quality, supply continuity, documentation, professional communication, and regulatory awareness.

Taj Medico provides pharmaceutical supply support designed around these requirements.

Consistent Pharmaceutical Supply

We aim to support regular procurement requirements through structured supply coordination and professional order management.

Quality-Oriented Approach

Our focus is on maintaining appropriate pharmaceutical manufacturing and quality-control practices to support consistent finished-product quality.

Professional Business Support

We provide product and commercial information required by legitimate pharmaceutical buyers and work to clarify supply requirements before order confirmation.

Domestic and Export Supply

We support authorized pharmaceutical procurement requirements across India and eligible international markets, subject to applicable regulatory conditions.

Documentation Support

Product-related quality and regulatory documentation can be discussed according to customer requirements and destination-market regulations.

D-Penicillamine USP 250mg Capsules for Pharmaceutical Distributors

Distributors require dependable suppliers who understand the importance of product continuity and regulatory compliance.

Our D-Penicillamine USP 250mg Capsules can be considered by authorized distributors looking to expand or maintain a prescription-pharmaceutical portfolio. We support discussions covering product specifications, packaging, supply requirements, and market-specific considerations.

For distributors operating in Mumbai, Maharashtra, Gujarat, other Indian states, or eligible international markets, supply arrangements can be evaluated according to applicable requirements.

D-Penicillamine 250mg Capsules – Key Pharmaceutical Information

D-penicillamine’s principal pharmaceutical applications can be summarized as follows:

Wilson’s disease: Helps promote elimination of excess copper.

Cystinuria: Can form a more soluble cystine complex and help reduce cystine stone formation.

Rheumatoid arthritis: Has immunomodulatory activity and has been used in selected severe cases.

These uses require physician-directed treatment. The medicine should not be promoted as an appropriate treatment for an individual without proper medical evaluation.

D-Penicillamine USP 250mg Capsules (Penici-D) are an important prescription pharmaceutical product with established applications in Wilson’s disease, cystinuria, and selected cases of severe rheumatoid arthritis. Its chelating and immunomodulatory properties make it clinically useful in specific circumstances, while its potential adverse effects make appropriate medical supervision and laboratory monitoring essential.

Taj Medico supports authorized pharmaceutical buyers searching for a D-Penicillamine USP 250mg Capsules Manufacturer, Supplier, and Exporter in India. Our associated pharmaceutical operations in Vapi, Gujarat provide a base for serving domestic requirements, including Mumbai and PAN-India markets, as well as eligible international procurement.